Multi-center, Open-label, Study of Safety and Tolerability of Chronic Intermittent Usage of Diazepam Nasal Spray in Epilepsy Patients With Cluster Seizures, Including Assessment of Olfaction and Reported Changes in Taste.
Phase of Trial: Phase II
Latest Information Update: 22 Feb 2017
At a glance
- Drugs Diazepam (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- Sponsors Acorda Therapeutics
- 17 Feb 2017 Status changed from completed to discontinued.
- 07 Oct 2016 Status changed from active, no longer recruiting to completed.
- 10 Jun 2016 Planned End Date changed from 1 Oct 2016 to 1 Sep 2016.